Gossamer Bio GOSS
NASDAQ GOSS
$10.71 -0.22 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Selling, General & Administrative (2018 - 2026)

Updated

Gossamer Bio (GOSS) reported Selling, General & Administrative of $8.9 million for Q2 2026, up 2.5% from $8.68 million a year earlier but down 52.5% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Gossamer Bio's Selling, General & Administrative came in at $47.94 million, up 36.1% year-over-year; for FY2025, it was $37.63 million, up 4.1% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of -5.4% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $36.13 million in FY2024 (-6.0%), $38.46 million in FY2023 (-19.2%), $47.61 million in FY2022 (+4.0%) and $45.78 million in FY2021 (-7.9%).
  • Five-year quarterly Selling, General & Administrative spans a low of $8.5 million in Q3 2024 and a high of $18.75 million in Q1 2026.
  • Year over year, Selling, General & Administrative has now increased in each of the last five quarters, with growth averaging 16.4% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q1 2026 (growth of 116.5%); the low point was Q4 2021 (a decline of 32.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $18.75 million (Q1 2026), $10.9 million (Q4 2025) and $9.39 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Gossamer Bio 42.84 Mn -430.56 Mn - 8.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.90 Mn
Mar 31, 2026 18.75 Mn
Dec 31, 2025 10.90 Mn
Sep 30, 2025 9.39 Mn
Jun 30, 2025 8.68 Mn
Mar 31, 2025 8.66 Mn
Dec 31, 2024 9.40 Mn
Sep 30, 2024 8.50 Mn
Jun 30, 2024 8.67 Mn
Mar 31, 2024 9.57 Mn
Dec 31, 2023 9.06 Mn
Sep 30, 2023 9.29 Mn
Jun 30, 2023 9.98 Mn
Mar 31, 2023 10.13 Mn
Dec 31, 2022 12.83 Mn
Sep 30, 2022 11.50 Mn
Jun 30, 2022 11.28 Mn
Mar 31, 2022 12.00 Mn
Dec 31, 2021 10.71 Mn
Sep 30, 2021 12.46 Mn
API Access

Gossamer Bio Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GOSS&period=max&api_key=YOUR_API_KEY